120 related articles for article (PubMed ID: 4883783)
1. Chemotherapy with hydroxyurea (NSC-32065) in renal cell carcinoma.
Nevinny HB; Hall TC
J Clin Pharmacol J New Drugs; 1968; 8(6):352-9. PubMed ID: 4883783
[No Abstract] [Full Text] [Related]
2. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
3. Combination vincristine (NSC-67574) and hydroxyurea (NSC-32065) for metastatic renal carcinoma.
Johnson DE; Rodriguez L; Holoye PY; Samuels ML
Cancer Chemother Rep; 1975; 59(6):1159-60. PubMed ID: 769957
[No Abstract] [Full Text] [Related]
4. Hormonal therapy in advanced renal cell carcinoma.
Wagle DG; Murphy GP
Cancer; 1971 Aug; 28(2):318-21. PubMed ID: 5566354
[No Abstract] [Full Text] [Related]
5. Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065).
Creasey WA; Capizzi RL; DeConti RC
Cancer Chemother Rep; 1970 Jun; 54(3):191-4. PubMed ID: 4946005
[No Abstract] [Full Text] [Related]
6. Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma.
Gottlieb JA; Frei E; Luce JK
Cancer Chemother Rep; 1971 Jun; 55(3):277-80. PubMed ID: 5115848
[No Abstract] [Full Text] [Related]
7. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
Fink DJ; Foye LV
Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
[No Abstract] [Full Text] [Related]
8. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
Slack NM; Jones R
Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
[No Abstract] [Full Text] [Related]
9. Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682).
Gailani S; Blais M
Cancer Chemother Rep; 1970 Jun; 54(3):187-90. PubMed ID: 4334087
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy in disseminated carcinoma of the breast.
Stutz FH; Blom J; Tormey DC
Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
[No Abstract] [Full Text] [Related]
11. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
[No Abstract] [Full Text] [Related]
12. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
Alberto P; Barrelet L; Chapuis B; Garcia B
Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
[No Abstract] [Full Text] [Related]
13. Hydroxyurea in stage D carcinoma of the prostate: a pilot study.
Lerner H; Malloy T; Cromie W; Longo S
J Urol; 1975 Sep; 114(3):425-9. PubMed ID: 1142528
[TBL] [Abstract][Full Text] [Related]
14. A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2.
Wilson WL; Ryzin JV; Weiss AJ; Frelick RW; Moss SE
Oncology; 1975; 31(5-6):293-309. PubMed ID: 174041
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
16. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
[No Abstract] [Full Text] [Related]
17. Hormonal therapy in metastatic hypernephroma.
Peterson LJ; Grimes JH; Dees JE; Anderson EE
Urology; 1974 Dec; 4(6):669-73. PubMed ID: 4454105
[No Abstract] [Full Text] [Related]
18. Piperazinedione in metastatic renal carcinoma.
Pasmantier MW; Coleman M; Kennedy BJ; Eagan R; Carolla R; Weiss R; Leone L; Silver RT
Cancer Treat Rep; 1977 Dec; 61(9):1731-2. PubMed ID: 340039
[No Abstract] [Full Text] [Related]
19. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
[No Abstract] [Full Text] [Related]
20. Treatment of advanced Hodgkin's disease with combination chemotherapy.
Mubashir BA; Shullenberger CC; Gamble JF
South Med J; 1973 Jul; 66(7):779-84. PubMed ID: 4752227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
